Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 2003;101:258-263
© 2003 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sebire, N. J.
Right arrow Articles by Regan, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sebire, N. J.
Right arrow Articles by Regan, L.

ORIGINAL RESEARCH

Placental Pathology, Antiphospholipid Antibodies, and Pregnancy Outcome in Recurrent Miscarriage Patients

N. J. Sebire, MD, M. Backos, MD, MRCOG, S. El Gaddal, MD, MRCOG, R. D. Goldin, MD, FRCPATH and L. Regan, MD, FRCOG

From the Departments of Histopathology and Obstetrics and Gynaecology, Imperial College School of Medicine at St. Mary’s,London, United Kingdom.

Address reprint requests to: N. J. Sebire, MD, St. Mary’s Hospital, Department of Histopathology, Paddington, London W2, United Kingdom; E-mail: njsebire{at}hotmail.com.

OBJECTIVE: To examine whether there are characteristic histological features in placentas from ongoing pregnancies of patients with a history of recurrent miscarriage, with and without primary antiphospholipid antibody syndrome, in relation to clinical pregnancy outcome.

METHODS: Patients attending a recurrent miscarriage clinic were investigated and treated according to an established protocol. One hundred twenty-one consecutive patients achieving a potentially viable pregnancy (at least 24 completed weeks’ gestation), including 60 primary antiphospholipid antibody syndrome–positive cases and 61 primary antiphospholipid antibody syndrome–negative cases were included. After delivery, placental pathologic examination was carried out by a pathologist unaware of the clinical details. Histological sections were examined by two pathologists independently. Pregnancy outcome and placental findings were reviewed in relation to the maternal antiphospholipid antibody status.

RESULTS: Pregnancy outcome was similar in primary antiphospholipid antibody syndrome–positive and primary antiphospholipid antibody syndrome–negative groups regarding gestation at delivery and antepartum obstetric complications. Several histological placental abnormalities were identified in both groups, but most pregnancies were clinically uncomplicated, with no significant placental abnormalities. In cases with pregnancy complications, the placental pathology was primarily that of uteroplacental vasculopathy, such as placental infarction and preeclampsia, but there were no specific placental lesions or patterns of abnormalities characteristic of primary antiphospholipid antibody syndrome–positive patients. A small subgroup of primary antiphospholipid antibody syndrome–positive patients may be at increased risk of development of maternal floor infarction or massive perivillus fibrin deposition.

CONCLUSION: There are no specific histopathologic placental abnormalities characteristic of treated patients with antiphospholipid antibody syndrome and poor reproductive history, but complications of uteroplacental disease are more common.




This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
S. M. Nelson and I. A. Greer
The potential role of heparin in assisted conception
Hum. Reprod. Update, August 12, 2008; (2008) dmn031v1.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
R. Cervera and J. Balasch
Bidirectional effects on autoimmunity and reproduction
Hum. Reprod. Update, May 22, 2008; (2008) dmn013v1.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
N. Di Simone, P.L. Meroni, M. D'Asta, F. Di Nicuolo, M.C. D'Alessio, and A. Caruso
Pathogenic role of anti-{beta}2-glycoprotein I antibodies on human placenta: functional effects related to implantation and roles of heparin
Hum. Reprod. Update, March 1, 2007; 13(2): 189 - 196.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
P. Jindal, L. Regan, E.O. Fourkala, R. Rai, G. Moore, R.D. Goldin, and N.J. Sebire
Placental pathology of recurrent spontaneous abortion: the role of histopathological examination of products of conception in routine clinical practice: a mini review
Hum. Reprod., February 1, 2007; 22(2): 313 - 316.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
S. Quenby, S. Mountfield, J. E. Cartwright, G. St. J. Whitley, and G. Vince
Effects of Low-Molecular-Weight and Unfractionated Heparin on Trophoblast Function
Obstet. Gynecol., August 1, 2004; 104(2): 354 - 361.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American College of Obstetricians and Gynecologists.